Chp (Cdc42 homologous protein) shares significant sequence and functional identity with the human Cdc42 small GTPase, and, like Cdc42, promotes formation of filopodia and activates the PAK serine/threonine kinase. However, unlike Cdc42, Chp contains unique amino and carboxyl terminal extensions. Here we determined whether Chp, like Cdc42, can promote growth transformation, and evaluated the role of the amino and carboxyl terminal sequences in Chp function. Surprisingly, we found that a GTPase-deficient mutant of Chp exhibited low transforming activity but that deletion of the amino terminus of Chp greatly enhanced its transforming activity. Thus, the amino terminus may serve as negative regulator of Chp function.
The carboxyl terminus of Cdc42 contains a CAAX (C=cysteine, A=aliphatic, X=terminal amino acid) tetrapeptide sequence that signals for posttranslational modification critical for Cdc42 membrane association and biological function. Although Chp lacks a CAAX motif, we found that Chp showed carboxyl terminusdependent localization to the plasma membrane and to endosomes.
Furthermore, an intact carboxyl terminus was required for Chp transforming activity.
However, treatment with inhibitors of protein palmitoylation, but not prenylation, caused Chp to mislocalize to the cytoplasm.
Thus, Chp depends on palmitoylation, rather than isoprenylation, for membrane association and function. In summary, Chp is implicated in cell transformation and the unique amino and carboxyl termini of Chp represent atypical mechanisms of regulation of Rho GTPase function.
The Rho family of small GTPases comprises one of the three major branches of the Ras superfamily (1, 2) . Rho-related proteins are a diverse group, with 22 human members identified to date. Of these, RhoA, Rac1, and Cdc42 have been the most extensively studied and best understood. Thus, the general properties of Rho family GTPases are based largely on the biochemical and biological characteristics of these three "classical" Rho GTPases (3) .
Rho family GTPases function as GDP/GTP-regulated binary switches. Nucleotide status is governed primarily by two classes of regulatory proteins (4, 5) .
Upon extracellular stimulation, guanine nucleotide exchange factors are activated and stimulate exchange of GDP for GTP, favoring the formation of the GTP-bound and active form of the GTPase. GTPase activating proteins stimulate the hydrolysis of GTP to GDP, promoting formation of the inactive GDPbound protein.
In their GTP-bound or "on" conformation, Rho GTPases bind to multiple functionally distinct effector proteins that stimulate cytoplasmic signaling networks that regulate changes in actin cytoskeletal organization, cell cycle progression, and gene expression (6) (7) (8) .
The majority of Rho family GTPases terminate in a CAAX (C = cysteine, A = aliphatic, X= terminal residue) tetrapeptide motif that signals for a series of posttranslational modifications (3) . Of greatest importance is the initial modification, which involves covalent attachment of a farnesyl or geranylgeranyl isoprenoid catalyzed by farnesyltransferase (FTase) or geranylgeranyltransferase I (GGTaseI), respectively (9, 10) . Protein prenylation, together with the subsequent proteolytic cleavage of the AAX residues and the carboxylmethylation of the now terminal prenylated cysteine, is critical for biological function, as it is necessary to promote Rho GTPase association with cellular membranes (11) (12) (13) (14) (15) .
As with Ras proteins, the CAAX-directed modifications alone are not sufficient for final Rho GTPase localization. Instead, a second carboxyl terminal targeting signal is needed to direct Ras and Rho GTPases to specific plasma or endomembrane locations. As with Ras proteins, the secondary signal is positioned immediately upstream of the CAAX motif and can consist of either a stretch of polybasic residues or a cysteine residue(s) that is post-translationally modified by addition of a palmitate fatty acid (16) . The CAAX-directed modifications, together with these second signals, are necessary and sufficient to facilitate Rho and Ras GTPase membrane association and localization. Additional carboxyl terminal sequences provide membrane association specificity, and direct localization of Rho GTPases to at least six distinct subcellular localization patterns (17) .
Chp (Cdc42 homologous protein; also called Wrch-2) is a recently identified member of the Rho GTPase family (18) .
Chp shares significant sequence identity (52%) and functional similarity with Cdc42 (19) .
While Chp has a conserved Rho GTPase domain, it differs from Cdc42 and other Rho GTPases in two notable ways. First, Chp contains additional 28 aminoand 16 carboxyl terminal residues that are not found in Cdc42, making Chp a significantly larger protein than Cdc42.
The amino terminal extension is proline-rich, and therefore may contain motifs recognized by Src homology 3 (SH3) domain containing proteins. Second, Chp lacks a carboxyl-terminal CAAX tetrapeptide motif and instead terminates in CFV. Surprisingly, despite the lack of a canonical CAAX motif, Chp still localizes to the plasma membrane like the other Rho-related GTPases (18) . Whether the carboxyl terminus of Chp undergoes isoprenyl modification and is important for Chp membrane association, subcellular localization, and biological activity has not been determined.
Constitutively activated Cdc42 causes growth transformation of rodent fibroblasts (20) (21) (22) (23) . Although elevated expression of Chp in some human tumors has been described (24), it is unknown whether Chp activation can also promote growth transformation. In the present study, we were surprised to find that deletion of the amino terminus promoted Chp transforming activity, suggesting that the amino terminus is a negative regulator of Chp function.
In addition, we determined that the carboxyl terminus was critical for Chp transforming activity as well as Chp association with the plasma and endomembranes. Unlike the classical Rho GTPases, however, Chp membrane association is not dependent on protein prenylation, and may instead depend on palmitoylation. These results show that despite their high degree of functional similarity, Cdc42 and Chp possess highly divergent mechanisms of regulation of function.
Materials and Methods
Molecular Constructs -pCAN mammalian expression vectors that encode Myc epitopetagged versions of wild type (WT), missense (G40V and S45N), and truncation mutants (ΔN, deletion of Chp residues 1-31; ΔC, deletion of Chp residues 204-236) of rat Chp were described previously (18) (Figure 1A) . Additional mammalian Chp expression vectors were created by ligation of cDNA sequences encoding wild type or mutant Chp (G40V, S45N, C227S, ΔN 40V, ΔC 40V, and ΔN/ΔC 40V) in frame with amino terminal sequences encoding a hemagglutinin (HA) epitope tag into the modified pBabe-puro-HAII retrovirus expression vector (a generous gift from T. Grana, UNC-Chapel Hill) or in frame with amino terminal sequences encoding green fluorescent protein (GFP) in the pEGFP-C3 expression vector (BD Biosciences Clonetech).
Additional cDNA sequences encoding other missense mutations were created by engineering the appropriate mutation by polymerase chain-mediated DNA amplification to encode the C227S and C234S point mutations in wild type or activated (G40V) Chp. Oligonucleotides designed to engineer the appropriate mutations were 5'-CTCTCTCGCTCTCGCTGGAAG-3' for mutation of codon 227 (C227S); 3'-GCGGGATCCTCAACAAAGGAGAAGAACTT CTTCC-5' for mutation of codon 234 (C234S) for expression in the pEGFP-c3-Chp or pBabe-HAII-3 Chp expression constructs. pEGFP expression vectors encoding GFP-tagged human H-Ras, Cdc42, Rac1, and Rab5 were provided by M. Philips (New York University) and have been described previously (17) . Tissue Culture, Transformation and Lipid Inhibition Assays -NIH 3T3 cells were maintained in Dulbecco's minimum Eagle's medium (DMEM) supplemented with 10% calf serum (Sigma) and 100 units/ml penicillin and 100 µg/ml streptomycin (designated growth medium). 293T cells were maintained in DMEM supplemented with 10% fetal calf serum (Sigma) and 100 units/ml penicillin and 100 µg/ml streptomycin (designated growth medium). For secondary focus formation transformation assays, we first established mass populations of NIH 3T3 cells that were stably-transfected with pBabe-HAII expression vectors encoding wild type (WT) Chp, Chp(40V), Chp(45N), ΔN-Chp(40V), ΔC-Chp(40V), or ΔN/ΔC-Chp(40V). After western blot analyses to verify expression of Chp protein, 1.6 x 10 5 cells were plated into 60 mm dishes and maintained in growth medium for three weeks, when the cells were fixed in 10% methanol and 10% acetic acid, and the number of foci of transformed cells was quantitated.
To evaluate growth in soft agar, NIH 3T3 cells that were stably transfected with pBabe-HAII constructs encoding wild type or mutant Chp proteins were used in soft agar assays according to procedures described previously (25) . For these analyses, 2.5x10 4 cells were plated in 0.4% agar per 60 mm dish. Cells were maintained in growth medium for three weeks, when the number of multi-cellular colonies was quantitated.
The cultures were then stained with 5% MTT (tetrazolium salt 3,[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) in phosphatebuffered saline at 37°C for 30 min and photographed. Fluorescence Microscopy -NIH 3T3 cells grown in growth medium were seeded in 35 mm dishes containing number 1.5 glass slides on the bottom (MatTek). Cells were transiently transfected with 0.5 µg of the pEGFP-C3 constructs encoding the indicated GFP fusion protein using LipofectAMINE PLUS lipid transfection reagents (Invitrogen). Three h after transfection, cells were washed and maintained in growth medium for 20 h. Live cells were visualized by fluorescence microscopy using a Zeiss Axioskop microscope with a FITC filter for fluorescence detection. To confirm localization to cellular membranes and endosomes, live cells were plated and transfected as described above, and viewed live using a Zeiss 510 LSM confocal microscope.
The highly selective farnesyltransferase (FTI-2153) and geranylgeranyltransferase I (GGTI-2166) inhibitors were a kind gift from Dr. S. Sebti (Moffatt Cancer Center) and were dissolved in dimethyl sulfoxide (DMSO) (26) . Lovastatin, cerulenin, and 2-bromopalmitate (2-BP) were purchased from Sigma and dissolved in ethanol. Control cultures were treated with the equivalent final concentration of ethanol or Me 2 SO (designated vehicle). In the inhibitor assays, cells were transfected as described above, washed, and incubated for 20 h with growth medium supplemented with 10 µM FTI-2153, 10 µM GGTI-2166, 100 µM 2-BP, 30 µM cerulenin, or 30 µM lovastatin.
To determine if Chp localized to mitochondrial or endosomal structures, NIH 3T3 cells that had been transfected as described above with 0.5 µg pEGFP-Chp were incubated with 1 µM MitoTracker Red (Molecular Probes) for 20 min at 37°C, or 30 µg/ml Alexa Fluor 594-conjugated transferrin (Molecular Probes) for 10 min at 37°C. Cells were washed, and visualized live using a Zeiss 510 LSM confocal microscope. Biotin-BMCC labeling -Direct analyses of protein palmitoylation were done as described in (27) . Briefly, 5 x 10 4 293T cells were seeded in 100 mm dishes, then transfected with 7 µg of the indicated pEGFP construct using a calcium phosphate transfection technique.
Twenty h after transfection, cells were lysed in lysis buffer and incubated with 5 µg of monoclonal living colors anti-GFP antibody (BD Biosciences JL-8) at 4°C for 1 h, at which point 50 µg protein G (Gibco BRL) was added to the lysates and incubated at 4°C for 1 h. Bound protein was washed and incubated with lysis buffer containing 50 mM Nethylmaleimide (NEM, Sigma) for 48 h at 4°C. Bound protein was then washed and treated with 1 M hydroxylamine pH 7.4 to cleave thioester bonds for 1 h at 25°C, washed again, and treated with 1-biotinamido-4-[4'-(maleimidomethyl)cyclohexanecarboxamido] butane (biotin-BMCC, Pierce), which recognizes free sulfhydryl groups, for 2 h at 25°C. Bound protein was washed again, resuspended in 20 µl 5X non-reducing sample loading buffer, and resolved by 12% polyacrylamide gel electrophoresis (PAGE). Protein was transferred to polyvinylidene difluoride membrane, and membrane was blocked in 5% bovine serum albumin in TBS with 0.1% Tween-20 at 25°C for 1 h. Labeled protein was detected by incubating with streptavidin-horseradish peroxidase (HRP; Pierce) and membrane was washed and exposed to x-ray film. Fifty µl of lysate was resolved by SDS-PAGE, transferred, incubated with anti-GFP primary antibody and anti-mouse IgG-HRP secondary antibody, and exposed to x-ray film to verify the presence of all GFP-tagged proteins.
RESULTS
To determine if Chp, like Cdc42, possesses transforming potential, we generated two missense mutants of Chp that are analogous two activated and transforming mutants of Cdc42 ( Fig. 1 ) (20) (21) (22) (23) . The Chp(40V) mutant contains a G40V mutation that is analogous to the G12V mutation that renders Cdc42 and other Rho GTPases constitutively GTP-bound and constitutively active.
The Chp(56L) mutant contains a Y56L mutation that is analogous to the F28L fast cycling Cdc42 mutation which increases GDP/GTP cycling. To assess the ability of Chp to cause morphological and growth transformation of NIH 3T3 mouse fibroblasts, we established NIH 3T3 cells that stably expressed wild type and mutant forms of Chp. Western blot analysis was performed to verify that there was equivalent levels of expression of each HA epitope-tagged Chp protein (data not shown).
Cells that expressed WT or mutant Chp did not exhibit any significant morphological difference when compared to empty vector-transfected cells (data not shown), indicating that, consistent with our observations with other activated Rho GTPases, activated Chp did not cause morphologic transformation of NIH 3T3 cells.
We next evaluated the ability of WT and mutants of Chp to cause growth transformation of NIH 3T3 cells. First, we determined if stable overexpression of Chp could enable cells to lose density-dependent growth inhibition and form foci of proliferating cells in confluent cultures by using a secondary focus formation assay. Expression of wild type Chp and Chp(56L) did not cause significant focus formation and only very modest focus forming activity was seen with Chp(40V) (Fig. 2A) . These results are similar to what we have found with the equivalent mutants of Cdc42, where no significant focus forming activity was seen (data not shown).
Second, we assessed the ability of cells that stably express Chp to acquire anchorageindependent growth potential by evaluation of colony formation in soft agar. When compared to empty vector-transfected cells, cells that expressed wild type Chp exhibited a limited ability to form colonies, and cells that expressed Chp(40V) or Chp(56L) exhibited only a modest increase in colony formation (Fig. 2B) .
Therefore, we concluded that putative GTPase-deficient or fast cycling mutants of Chp do not possess potent transforming activity when assessed in two different growth transformation assays.
Chp possesses additional amino and carboxyl terminal sequences not found in Cdc42 (Fig. 1A) . Therefore, we next determined if deletion of these sequences could influence Chp transforming activity. The ΔN-Chp truncation mutant lacks the first 31 amino acids unique to Chp, whereas the ΔC-Chp truncation mutant lacks the last 33 unique amino acids, and ΔN/ΔC-Chp lacks both amino and carboxyl terminal extensions (Fig. 1B) . Surprisingly, we found that cells expressing ΔN-Chp (WT or 40V) exhibited significant focus forming activity as well as colony formation in soft agar ( Figs. 2A and 2B ). In contrast, deletion of the carboxyl terminal sequences abolished the transforming activity of wild type or GTPase-deficient Chp (40V) (Fig.  2B) . These results suggest that the amino terminus may play a negative regulatory role in Chp activity, while the carboxyl terminus is essential for Chp function.
The carboxyl terminal CAAX motif of Cdc42 is required for posttranslational modification by a geranylgeranyl isoprenoid lipid, which promotes Cdc42 membrane association and is therefore essential for Cdc42-mediated transformation. Since Chp lacks the CAAX motif found in Cdc42 and many other Rho family GTPases, we were surprised to find that the carboxyl terminus was essential for Chp transforming activity.
However, other Ras superfamily proteins also lack carboxyl terminal CAAX motifs, yet exhibit critical dependence on the carboxyl terminus for membrane association and function (28, 29) . Therefore, we evaluated the possibility that the importance of the carboxyl terminus for Chp transforming activity was due to its role in facilitating Chp membrane association and subcellular location. We previously determined that Myc epitope-tagged Chp showed localization to Golgi membranes when analyzed in fixed porcine aortic endothelial cells (18) . However, fixation artifacts have been described for localization analyses of Rho GTPases (17) . Additionally, since we wanted to determine Chp localization in the same cell type that was used for our biological assays, we utilized live cell analyses of green fluorescent protein (GFP)-tagged versions of Rho GTPases in NIH 3T3 cells to evaluate the role of carboxyl terminal sequences in promotion of membrane association and regulation of subcellular location. Therefore, we generated an expression vector for GFP-tagged Chp and compared the subcellular location of Chp to that of GFP-tagged versions of Cdc42 and Rac1 in live NIH 3T3 cells. In agreement with previous studies, GFP alone showed a nucleoplasmic and cytoplasmic localization, whereas Cdc42 exhibited a cytoplasmic and endomembrane distribution, and Rac1 was associated mainly with the plasma membrane (17) . In contrast, we observed that a fraction of GFP-Chp was associated with the plasma membrane and a fraction showed a punctate localization that was distinct from the Golgi membrane-associated localization that was seen with Cdc42 (30) (Fig. 3A) . To determine the precise subcellular localization of Chp, we treated live cells that expressed GFP-Chp with MitoTracker Red, which is a mitochondrial marker, and transferrin conjugated to Alexa Fluor 594, which labels early endosomal structures. Visualization of a merged image of GFP-Chp and MitoTracker showed that Chp did not co-localize with mitochondria. However a significant amount of GFP-Chp colocalized with transferrin, which suggests that the punctate cytoplasmic distribution was Chp association with early endosomes (Fig 4) . Some Ras family GTPases, in particular those associated with endomembranes and involved in regulation of vesicular trafficking, show nucleotide-dependent subcellular localization (31) . However, we found that both the putative GTPbound Chp(40V) and GDP-bound Chp(S45N) mutants exhibited subcellular distribution comparable to the wild type protein (Fig. 3A) .
Since deletion of the amino terminus activated Chp transforming activity, we determined if the amino terminus was important for regulating Chp subcellular localization. The subcellular distribution of GFP-ΔN-Chp was similar to that of wild type GFP-Chp, indicating that the enhanced transforming activity of this truncation mutant was not a consequence of gross alteration in subcellular localization. We then determined the role of the carboxyl terminus in Chp subcellular localization. We found that ∆C-Chp exhibited a loss of plasma membrane association, and instead showed a diffuse cytoplasmic distribution (Fig. 3B) . ΔN/ΔC-Chp also exhibited the same perturbation in subcellular localization. Hence, our data suggest that the loss of transforming activity seen with removal of the carboxyl terminus was most likely due to the loss of plasma membrane localization.
Although the carboxyl terminus of Chp does not possess any known prenylation recognition motifs, it does contain two cysteine residues at positions 227 and 234 that may become modified by isoprenoid or palmitate groups. Therefore, we evaluated the importance of the two carboxyl terminal cysteine residues in Chp membrane association and transforming activity. Similar to deletion of the entire carboxyl-terminal extension, mutation of the cysteine at position 234 (C234S), but not the upstream cysteine at position 227 (C227S), caused a loss of plasma and endomembrane association (Fig.  5A ). Transformation analyses with Chp(40V/234S) emphasized the importance of localization in Chp function, as Chp(40V/234S) showed a complete loss of colony formation in soft agar (Fig. 5B) as well as focus-forming activity (data not shown). Surprisingly, cells that expressed Chp(40V/227S) showed enhanced ability for colony formation when compared to Chp(40V) (Fig. 5B) . Furthermore, mutation of C227 in wild type Chp [Chp(227S)] potently activated the ability of Chp to promote growth in soft agar (Fig. 5B) . Thus, C234 is essential for proper Chp subcellular location and transforming activity, whereas C227 may serve a negative regulatory role in Chp function.
Because we found that the C234 is critical for Chp localization and function, we evaluated the possibility that this cysteine residue may comprise a novel prenylation signal sequence. To determine the importance of prenylation in Chp localization, we utilized pharmacologic inhibitors that specifically inhibited FTase or GGTaseI, and treated NIH 3T3 cells that transiently expressed GFP fusion proteins of Chp with these reagents. We also treated cells that expressed GFP-tagged H-Ras (modified by FTase), Rac1 (modified by GGTaseI), and Rab5 (modified by GGTaseII), to control for the specificity of the inhibitors. As expected, treatment of NIH 3T3 cells with FTI-2153, a specific inhibitor of FTase and not GGTaseI or GGTaseII (26) , caused the normally farnesylated and membrane-bound GFP-H-Ras to become mislocalized to the cytosol (Fig. 6 ). The specificity of the FTI treatment was demonstrated by the fact that FTI-2153 treatment did not alter the location of Rac1 or Rab5, which are tethered to membranes by GGTaseI-or GGTaseII-catalyzed addition of a geranylgeranyl isoprenoid, respectively. Since Chp localization was not altered upon FTI treatment, we conclude that Chp localization is not dependent on the activity of FTase.
We next determined if Chp localization depended on GGTaseI-mediated prenylation. As expected, treatment with GGTI-2166, a specific inhibitor of GGTaseI and not FTase or GGTaseII (26) , disrupted the localization of Rac1, but not HRas or Rab5 (Fig. 6) . However, Chp localization was also unchanged, and hence, is not dependent on the activity of GGTaseI.
Currently, no specific inhibitors of GGTaseII have been described, and it is also possible that Chp may be a substrate for an unidentified prenyltransferase. To determine if Chp may be a substrate for GGTaseII or other prenyltransferases, we utilized lovastatin, an inhibitor of mevalonate biosynthesis (an essential step for all isoprenoid synthesis), to inhibit prenylation. As expected, lovastatin treatment disrupted localization of H-Ras, Rac1, and Rab5 (Fig. 6) . However, no change in the localization of Chp was seen. While these analyses do not eliminate the possibility that Chp undergoes prenylation, it does argue that, in contrast to the classical Rho GTPases, Chp membrane association and subcellular localization does not depend on isoprenoid modification.
Previous studies showed that geneticallyengineered variants of Ras proteins could be targeted to the plasma membrane in the absence of prenylation with carboxyl terminal cysteine residues modified by the palmitate fatty acid and basic amino acid-rich sequences (32, 33) . The Chp carboxyl terminal cysteine residues are flanked by multiple lysine and arginine residues. Hence, we evaluated the possibility that Chp subcellular localization may be dependent on palmitoylation. We treated NIH 3T3 cells that expressed GFP-Chp G40V with a palmitate analog, 2-bromopalmitate (2-BP), a widely used palmitoylation inhibitor used to evaluate the role of protein palmitoylation in protein targeting (34, 35) .
For example, previous studies showed that 2-BP treatment caused mislocalization of the palmitoylated H-Ras, RhoB, and TC10 GTPases (17, 36) In agreement with previous observations (17,36), we found that 2-BP treatment caused HRas to mislocalize to endomembranes structures, most likely to the Golgi apparatus (Fig. 7) . In comparison, non-palmitoylated Rab5 localization was not altered by 2-BP treatment, indicating that the drug is specifically efficacious in blocking modification by palmitate. In contrast, 2-BP treatment caused Chp to mislocalize to the cytoand nucleoplasm of the cell, indicating that the localization of Chp is dependent on palmitoylation. We also observed similar results by treatment with cerulenin (data not shown), another widely utilized inhibitor of protein palmitoylation (37, 38) , providing further evidence for a key role of palmitoylation in Chp plasma membrane association and subcellular localization.
Because we found that Chp localization was critically dependent on palmitoylation, we next directly determined that Chp is modified by a palmitate fatty acid. We used a novel technique described in detail in (27) , which involves hydrolyzing the thioester bond that links palmitate groups to cysteines and treating with a biotinylated compound that recognizes and binds to the free sulfhydryl group generated upon cleavage of the thioester bond. Using this technique, we were able to detect palmitate modification of H-Ras, which is palmitoylated, but not K-Ras, which is not (Fig.  8) . As expected, we were also able to determine that Chp was post-translationally modified by palmitate, and that palmitate addition was inhibited by a C234S mutation. Chp C227S had similar amounts of labeling as wild-type Chp, suggesting that Chp contains a single palmitoylation site in the carboxyl terminus, at residue C234. Finally, we found that, as expected, Chp 227S and Chp 234S both retained the ability to bind to PAK PBD, suggesting that Chp 234S is unable to affect cellular transformation due to mislocalization of the GTPase rather than to a deficiency in effector binding (data not shown).
DISCUSSION
Although Chp shares significant sequence and functional similarity with Cdc42 (18), Chp contains additional unique amino and carboxyl terminal sequences that suggest that the properties and regulation of Chp will be distinct and divergent from those of Cdc42. In this study, we found that Chp, like Cdc42, can cause growth transformation of rodent fibroblasts. However, unlike Cdc42, potent transforming activity was unmasked by deletion of the amino terminus of Chp, suggesting that the amino terminus is a negative regulator of Chp function. Additionally, as with Cdc42, the carboxyl terminus of Chp was critical for membrane association and subcellular localization, as well as transforming activity. Surprisingly, the membrane-targeting function of the carboxyl terminus was not dependent on isoprenoid modification, but is most likely mediated by addition of a palmitate fatty acid. The unique and opposing regulatory roles of the amino and carboxyl termini of Chp distinguish Chp from Cdc42 and the other classical mammalian Rho family GTPases.
The finding that the amino terminus of Chp acts as a negative regulator of transformation is surprising, given that no other Rho GTPase has been found to be regulated in this way. Rnd proteins are members of the Rho GTPase family and also contain additional amino terminal sequences, but these sequences appear to be necessary, rather than inhibitory, for biological activity (39) . Since the G40V mutant, which should be persistently GTP-bound, showed only limited transforming activity, it suggests that regulation via the amino terminus must also be involved in controlling Chp activity. We also determined that deletion of the amino terminus of the related Wrch-1 protein caused activation of Wrch-1 transforming activity (40) . One possible interpretation for the activated phenotype seen with the amino terminal truncation mutant is that the amino terminus has an auto-inhibitory function. The 28 amino acid extension is prolinerich, which suggests that it may serve as a binding site for SH3 domains that recognize proline-rich sequences (41,42).
The association of such proteins with the amino terminus of Chp may then overcome the amino terminal negative regulation. Support for this possibility is provided by our finding that the Grb2 SH3 domain-containing adaptor protein associates with the amino terminus of Wrch-1 and promotes Wrch-1 interaction with its downstream effector PAK (40) . Our recent unpublished observations suggest that Chp is likewise able to bind to recombinant Grb2, and that binding depends on an intact amino terminus. Whether Grb2 binding will similarly facilitate PAK binding remains to be elucidated. Structural determination to delineate the spatial relationship between the amino terminus and the G domain will also aid in elucidating the role of the amino terminus in regulation of Chp function.
The effector pathways through which Chp exerts its growth-promoting effects have yet to be determined, but it is possible that Chp, like Cdc42, may signal through the γCOP or PAR6 effector pathways found to promote Cdc42-mediated transformation (43) (44) (45) . One previous study found Chp interaction with several canonical Cdc42 effectors (including N-WASP, MLK3, PAR6, and PAK4), but not WASP or other well-known effectors of Cdc42 signaling (CIP4, SPEC1, p50RhoGAP, or PAK1) (19) . It is unknown at this point if Chp is able to interact with these effectors of Cdc42 signaling in vivo, or if these effectors are important for Chp-mediated transformation. While there is some evidence that Cdc42 and Chp may share some effectors, it is also likely that Chp interacts with its own unique set of effectors. Determining the effectors through which Chp signals to promote growth is an important future direction of this work.
Our previous subcellular localization analyses of Myc epitope-tagged Chp, when done in fixed porcine aortic endothelial cells, described Golgi localization (18) . However, our live cell analyses of GFP fusion proteins found that Chp localized to the plasma and endomembranes of NIH 3T3 cells. As suggested previously, these different results may be due to fixation artifacts (17) , or alternatively, cell type differences in Chp localization.
Under the same conditions of analyses, we found that GFP-Chp showed a distinct localization pattern from that of GFPCdc42, which is predominately found on the Golgi (30). Our co-labeling analyses with Chp and transferrin, an endosomal marker, determined that the punctate cytoplasmic localization of GFP-Chp is most likely Chp association with early endosomes.
While removal of the amino terminus did not alter the gross subcellular localization of GFPChp, removal of the carboxyl terminus caused the protein to mislocalize to the cytoplasm. GFP-∆N/∆C-Chp exhibited the same cytoplasmic localization as GFP-∆C-Chp. This result may explain the inability of the supposedly active ∆N/∆C-Chp(40V) mutant to transform NIH 3T3 cells in the focus formation assays; Chp must be at the plasma membrane in order to affect transformation. We found previously that deletion of the carboxyl terminus impaired Chp interaction with PAK and WASP (18) , and speculated that this may have been due to a conformation change. However, since we found in the present study that a single missense mutation of a carboxyl terminal cysteine disrupted localization and transforming activity, and yet still retained the ability to bind to PAK, this argues that the targeting function of the carboxyl terminus is crucial for Chp function.
Previous studies established that the majority of Rho GTPases are tethered to cellular membranes by prenyl groups. In some cases, palmitate modification serves as a second signal to facilitate full membrane association in function (9, 10) . Exceptions to this rule do exist in the form of the recently described Miro-1 and -2 and RhoBTB1 and 2 proteins, which also lack known consensus prenylation signal sequences at their carboxyl termini and yet are localized to mitochondria and vesicles, respectively (19, 46) . However, to date, no mammalian Ras or Rho GTPases have been found to exhibit prenylationindependent, palmitoylation-dependent membrane association and function. Thus, although Chp and Cdc42 share strong sequence and functional similarity, divergence in carboxyl terminal membrane targeting is likely to contribute to the functional differences seen with these otherwise closely related GTPases.
While the carboxyl termini of other Ras (H-Ras and N-Ras) and Rho (RhoB and TC10) GTPases are modified by a palmitate fatty acid, modification by a farnesyl or geranylgeranyl isoprenoid is a necessary precursor to this step (16, 47) .
Thus, the finding that Chp is palmitoylated without apparently being prenylated defines a novel mechanism for palmitoylation not previously identified in any naturally occurring mammalian Ras or Rho family GTPase. Two previous studies have found that genetically engineered variants of Ras proteins that lack a CAAX motif and instead contain cysteine residues together with polybasic residues at their carboxyl termini are efficient substrates for palmitoylation and able to associate with the plasma membrane (32, 33) .
Chp contains two candidate palmitoylation sites in the carboxyl terminus, and, by treatment with inhibitors of palmitoylation and mutational analysis, we determined that Chp localization to cellular membranes is critically dependent on palmitoylation. We also verified that Chp is modified by palmitate in vivo. We suspect that Chp is palmitoylated primarily at the C234 site, as a mutation at this site precluded palmitate addition, whereas the C227S mutant had comparable levels of palmitate labeling as seen with wild-type Chp. We have observed similar results for the highly related Wrch-1 protein, where mutation of the cysteine residue corresponding to C234 in Chp also caused a loss of Wrch-1 transforming activity, whereas mutation of an upstream cysteine residue also enhanced transforming activity (A.C. Berzat et al., submitted)
1 . Although Wrch-1 terminates with an apparent CAAX motif, Wrch-1, like Chp, is not prenylated and is instead modified by palmitoylation. Finally, the mechanism by which a mutation at position C227 results in higher transforming activity remains unclear. Perhaps the loss of palmitate modification at C277 results in Chp association with a discrete plasma membrane microdomain where effector activation required for transformation is favored.
In addition to the cysteine residues, Chp contains a stretch of basic amino acids in its carboxyl terminus.
Thus Chp may rely on palmitoylation and basic residues to reach cellular membranes. While the majority of plant Rho GTPases show prenylation-dependent membrane association, it has been described that some plant Rho-like GTPases also possess prenylationindependent, palmitoylation-dependent mechanisms of membrane targeting (48, 49) . However, their carboxyl terminal sequences are also distinct from those of Chp or Wrch-1, with no flanking basic residues.
In summary, similar to what has been established for other Rho family GTPases, membrane association is critical for the biological function of Chp. However, in contrast to the classical Rho family GTPases, the membrane association of Chp and Wrch-1 is dependent on carboxyl terminal modification by palmitate, rather than an isoprenoid lipid. Work is currently underway to elucidate the importance of the basic amino acids in the carboxyl terminus of Chp in membrane localization. The distinct mechanism by which this unique branch of the Rho GTPase family is targeted to membranes demonstrates the diverse mechanisms by which a common biochemical switch can be varied to serve distinct functions in cell physiology. GTPases. Amino acid sequences were retrieved from the NCBI database, and aligned using CLUSTAL-W. Rat (r), mouse (m) and human (h) Chp orthologs have been identified. Human Chp, also called Wrch-2, shares 55% and 43% amino acid identity, respectively, with human Wrch-1 and Cdc42. Underlined regions connote amino acids deleted in the ∆N and ∆C mutants of Chp. Highlighted grey residues connote sites where mutations were introduced to generate gain or loss of function mutants of Chp. B, Truncation and missense mutants of rat Chp. Chp residue G40 is analogous the G12 of Cdc42 and mutation of this residue with Val results in a GTPase-deficient, mutant of Cdc42 (51) . Chp residue Y56 is analogous to Cdc42 residue F28 and substitution at this position with Leu results in a fast cycling, activated mutant of Cdc42.ΔN-Chp(40V) and ΔC-Chp(40V) are amino or carboxyl terminally truncated variants that lack these additional sequences, and ΔN/C-Chp(40V) is truncated at both the amino and carboxyl termini. Chp(40V/227S) and Chp(40V/234S) were created to elucidate the role of carboxylterminal cysteine residues in Chp localization and biological activity. Chp is modified by palmitate fatty acid. 293T cells were transiently transfected with the indicated pEGFP constructs, lysed 48 h after transfection, and subjected to a biotin-BMCC labeling assay (27) . Nonpalmitylated K-Ras was included as a negative control for this assay. Data shown are representative of five independent experiments. An equivalent concentration of GFP and GFP-tagged versions of Chp, Chp 227S, Chp 234S, K-Ras and H-Ras protein was used in the assays.
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